Wael El-Sadda

Learn More
Less than 1% of all breast cancer cases are found in men, who reportedly have inferior outcomes compared with matched women patients. Ethnic differences may also affect their prognosis. Here, we investigated overall survival (OS) and major prognostic factors for male breast cancer (MBC) in a cohort of Egyptian patients. We retrospectively analyzed OS in a(More)
Background: The treatment of breast cancer in large breast patients represents a great challenge to both surgical oncologist and radiation oncologist. The aim of this study is to evaluate the outcome of inferior pedicle therapeutic mammoplasty in large-breasted patients with upper quadrants early breast cancer. Methods: Thirty five large-breasted patients(More)
The influence of rituximab therapy on prognosis and hepatic toxicity (HT) in patients with hepatitis C virus (HCV)-positive diffuse large B-cell lymphoma (DLBCL) is unclear. Thus, we assessed HT and clinical outcome in patients with DLBCL and HCV infection who received rituximab-containing immunochemotherapy. We carried out a prospective analysis on a total(More)
Background: Nasopharyngeal carcinoma (NPC) is the most common head and neck carcinoma in Egypt. The standard treatment of locally advanced carcinoma of the nasopharynx is cisplatin based chemotherapy followed by locoregional radiotherapy. Taxotere in combination with the standard cisplatin-5-FU as neoadjuvant for patients with locally advanced NPC had(More)
  • 1